Skip to content

Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation

Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation (PAPHOME)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06611800
Acronym
PAPHOME
Enrollment
256
Registered
2024-09-25
Start date
2024-10-01
Completion date
2024-10-07
Last updated
2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Care

Brief summary

Retrospective data collection on the files of patients cared for by the mobile palliative care team of the William Morey Hospital Center who died in 2022.

Detailed description

Retrospective selection of patients and collection of data : pathology, identified risk, presence of caregiver, end-of-life wishes, characteristics of palliative care treatment, circumstances of death. Comparison of two groups : presence or absence of personalized advance prescriptions.

Interventions

None listed

Sponsors

Centre Hospitalier William Morey - Chalon sur Saône
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Minimum 18 years old * Taken care of once in their place of life by a palliative care team * Died between 01/01/2022 and 12/31/2022 in William Morey Hospital Center

Exclusion criteria

none

Design outcomes

Primary

MeasureTime frameDescription
Know if the presence of advance prescriptions can lead to a reduction in the number of emergency admissions for an avoidable reason by its management by a mobile palliative care team (with a maximum of 6 months before death)A yearCollection of corresponding variables : presence/absence advance prescriptions ; number of emergency admissions for an avoidable reason

Secondary

MeasureTime frameDescription
Reduction in the number of emergency admissions for all reasons in their last 6 months of life.A yearCollection of corresponding variables
Describe conditions of death: location, respect for the wishes of a death at home and notion of a calm death collected from the familyA yearCollection of corresponding variables
Describe the treatments used for PAPs: Analgesics, Anxiolytics, Anti-secretory drugs, Neuroleptics, Anti-histamines, Anti-emeticsA yearCollection of corresponding variables

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026